Procetofen

Procetofen Brand names, Procetofen Analogs

Procetofen Brand Names Mixture

No information avaliable

Procetofen Chemical_Formula

C₂₀H₂₁ClO₄

Procetofen RX_link

http://www.rxlist.com/cgi/generic3/fenofibrate.htm

Procetofen fda sheet

Procetofen FDA

Procetofen msds (material safety sheet)

Procetofen MSDS

Procetofen Synthesis Reference

No information avaliable

Procetofen Molecular Weight

360.831 g/mol

Procetofen Melting Point

80.5 °C

Procetofen H₂O Solubility

0.25mg/ml at 25 °C

Procetofen State

Solid

Procetofen LogP

5.575

Procetofen Dosage Forms

Capsule; Tablet

Procetofen Indication

For use as adjunctive therapy to diet to reduce elevated LDL-C, Total-C,Triglycerides and Apo B, and to increase HDL-C in adult patients with primary hypercholesterolemia or mixed dyslipidemia (Fredrickson Types IIa and IIb)

Procetofen Pharmacology

Fenofibrate is a lipid regulating agent indicated as adjunctive therapy to diet to reduce elevated LDL-C, Total-C,Triglycerides and Apo B, and to increase HDL-C in adult patients with primary hypercholesterolemia or mixed dyslipidemia (Fredrickson Types IIa and IIb). Fenofibrate is also indicated as adjunctive therapy to diet for treatment of adult patients with hypertriglyceridemia (Fredrickson Types IV and V hyperlipidemia). Fenofibric acid, the active metabolite of Fenofibrate, produces reductions in total cholesterol, LDL cholesterol, apolipoprotein B, total triglycerides and triglyceride rich lipoprotein (VLDL) in treated patients. In addition, treatment with fenofibrate results in increases in high density lipoprotein (HDL) and apoproteins apoAI and apoAII.

Procetofen Absorption

Fenofibrate is well absorbed from the gastrointestinal tract. After absorption, fenofibrate is mainly excreted in the urine in the form of metabolites, primarily fenofibric acid and fenofibric acid glucuronide

Procetofen side effects and Toxicity

LD₅₀=1600 mg/kg (Oral, in mice); Investigated as a teratogen and reproductive hazard.

Procetofen Patient Information